Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501580 | SCV000595551 | uncertain significance | not specified | 2017-02-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000914143 | SCV001059304 | likely benign | not provided | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000914143 | SCV001800917 | likely benign | not provided | 2018-12-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30924900) |
Ambry Genetics | RCV002524219 | SCV003681362 | likely benign | Inborn genetic diseases | 2021-09-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000914143 | SCV004699808 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | LAMC3: BP4 |
Prevention |
RCV003925475 | SCV004740918 | likely benign | LAMC3-related condition | 2023-02-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |